AbbVie Inc

1ABBV

Company Profile

  • Business description

    AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

  • Contact

    1 North Waukegan Road
    North ChicagoIL60064-6400
    USA

    T: +1 847 932-7900

    E: [email protected]

    https://www.abbvie.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    55,000

Stocks News & Analysis

stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.
stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,937.7041.70-0.46%
CAC 407,818.2832.15-0.41%
DAX 4024,295.9355.110.23%
Dow JONES (US)44,693.91316.38-0.70%
FTSE 1009,138.3776.880.85%
HKSE25,406.55260.63-1.02%
NASDAQ21,057.9637.940.18%
Nikkei 22541,570.24256.10-0.61%
NZX 50 Index12,875.1570.020.55%
S&P 5006,363.354.440.07%
S&P/ASX 2008,669.4040.00-0.46%
SSE Composite Index3,591.4114.32-0.40%

Market Movers